Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Alzheimer's Treatment Drug Market Insights, Forecast to 2029

Global Alzheimer's Treatment Drug Market Insights, Forecast to 2029

Industry: Pharma & Healthcare

Published: 2023-05-31

Pages: 94 Pages

Report ld: 1154805

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global Alzheimer's Treatment Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Alzheimer's Treatment Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Alzheimer's Treatment Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Alzheimer's Treatment Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key manufacturers of Alzheimer's Treatment Drug include AbbVie, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson and Johnson and Lundbeck, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes:
This report presents an overview of global market for Alzheimer's Treatment Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Alzheimer's Treatment Drug, also provides the sales of main regions and countries. of the upcoming market potential for Alzheimer's Treatment Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alzheimer's Treatment Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Alzheimer's Treatment Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Alzheimer's Treatment Drug sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including AbbVie, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson and Johnson and Lundbeck, etc.

Report Metric
Details
Report Title
Global Alzheimer's Treatment Drug Market Insights, Forecast to 2029
Global Alzheimer's Treatment Drug Companies Covered
AbbVie, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson and Johnson, Lundbeck
Global Alzheimer's Treatment Drug Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Alzheimer's Treatment Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Alzheimer's Treatment Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alzheimer's Treatment Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

Table of Contents

 1 Study Coverage
    1.1 Alzheimer's Treatment Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Alzheimer's Treatment Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
        1.2.2 Donepezil
        1.2.3 Memantine
        1.2.4 Rivastigmine
    1.3 Market by Application
        1.3.1 Global Alzheimer's Treatment Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
        1.3.2 Early to Moderate Stages
        1.3.3 Moderate to Severe Stages
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Executive Summary
    2.1 Global Alzheimer's Treatment Drug Sales Estimates and Forecasts 2018-2029
    2.2 Global Alzheimer's Treatment Drug Revenue by Region
        2.2.1 Global Alzheimer's Treatment Drug Revenue by Region: 2018 VS 2022 VS 2029
        2.2.2 Global Alzheimer's Treatment Drug Revenue by Region (2018-2023)
        2.2.3 Global Alzheimer's Treatment Drug Revenue by Region (2024-2029)
        2.2.4 Global Alzheimer's Treatment Drug Revenue Market Share by Region (2018-2029)
    2.3 Global Alzheimer's Treatment Drug Sales Estimates and Forecasts 2018-2029
    2.4 Global Alzheimer's Treatment Drug Sales by Region
        2.4.1 Global Alzheimer's Treatment Drug Sales by Region: 2018 VS 2022 VS 2029
        2.4.2 Global Alzheimer's Treatment Drug Sales by Region (2018-2023)
        2.4.3 Global Alzheimer's Treatment Drug Sales by Region (2024-2029)
        2.4.4 Global Alzheimer's Treatment Drug Sales Market Share by Region (2018-2029)
    2.5 US & Canada
    2.6 Europe
    2.7 China
    2.8 Asia (excluding China)
    2.9 Middle East, Africa and Latin America

 3 Competition by Manufactures
    3.1 Global Alzheimer's Treatment Drug Sales by Manufacturers
        3.1.1 Global Alzheimer's Treatment Drug Sales by Manufacturers (2018-2023)
        3.1.2 Global Alzheimer's Treatment Drug Sales Market Share by Manufacturers (2018-2023)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Alzheimer's Treatment Drug in 2022
    3.2 Global Alzheimer's Treatment Drug Revenue by Manufacturers
        3.2.1 Global Alzheimer's Treatment Drug Revenue by Manufacturers (2018-2023)
        3.2.2 Global Alzheimer's Treatment Drug Revenue Market Share by Manufacturers (2018-2023)
        3.2.3 Global Top 10 and Top 5 Companies by Alzheimer's Treatment Drug Revenue in 2022
    3.3 Global Key Players of Alzheimer's Treatment Drug, Industry Ranking, 2021 VS 2022 VS 2023
    3.4 Global Alzheimer's Treatment Drug Sales Price by Manufacturers
    3.5 Analysis of Competitive Landscape
        3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.5.2 Global Alzheimer's Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.6 Global Key Manufacturers of Alzheimer's Treatment Drug, Manufacturing Base Distribution and Headquarters
    3.7 Global Key Manufacturers of Alzheimer's Treatment Drug, Product Offered and Application
    3.8 Global Key Manufacturers of Alzheimer's Treatment Drug, Date of Enter into This Industry
    3.9 Mergers & Acquisitions, Expansion Plans

 4 Market Size by Type
    4.1 Global Alzheimer's Treatment Drug Sales by Type
        4.1.1 Global Alzheimer's Treatment Drug Historical Sales by Type (2018-2023)
        4.1.2 Global Alzheimer's Treatment Drug Forecasted Sales by Type (2024-2029)
        4.1.3 Global Alzheimer's Treatment Drug Sales Market Share by Type (2018-2029)
    4.2 Global Alzheimer's Treatment Drug Revenue by Type
        4.2.1 Global Alzheimer's Treatment Drug Historical Revenue by Type (2018-2023)
        4.2.2 Global Alzheimer's Treatment Drug Forecasted Revenue by Type (2024-2029)
        4.2.3 Global Alzheimer's Treatment Drug Revenue Market Share by Type (2018-2029)
    4.3 Global Alzheimer's Treatment Drug Price by Type
        4.3.1 Global Alzheimer's Treatment Drug Price by Type (2018-2023)
        4.3.2 Global Alzheimer's Treatment Drug Price Forecast by Type (2024-2029)

 5 Market Size by Application
    5.1 Global Alzheimer's Treatment Drug Sales by Application
        5.1.1 Global Alzheimer's Treatment Drug Historical Sales by Application (2018-2023)
        5.1.2 Global Alzheimer's Treatment Drug Forecasted Sales by Application (2024-2029)
        5.1.3 Global Alzheimer's Treatment Drug Sales Market Share by Application (2018-2029)
    5.2 Global Alzheimer's Treatment Drug Revenue by Application
        5.2.1 Global Alzheimer's Treatment Drug Historical Revenue by Application (2018-2023)
        5.2.2 Global Alzheimer's Treatment Drug Forecasted Revenue by Application (2024-2029)
        5.2.3 Global Alzheimer's Treatment Drug Revenue Market Share by Application (2018-2029)
    5.3 Global Alzheimer's Treatment Drug Price by Application
        5.3.1 Global Alzheimer's Treatment Drug Price by Application (2018-2023)
        5.3.2 Global Alzheimer's Treatment Drug Price Forecast by Application (2024-2029)

 6 US & Canada
    6.1 US & Canada Alzheimer's Treatment Drug Market Size by Type
        6.1.1 US & Canada Alzheimer's Treatment Drug Sales by Type (2018-2029)
        6.1.2 US & Canada Alzheimer's Treatment Drug Revenue by Type (2018-2029)
    6.2 US & Canada Alzheimer's Treatment Drug Market Size by Application
        6.2.1 US & Canada Alzheimer's Treatment Drug Sales by Application (2018-2029)
        6.2.2 US & Canada Alzheimer's Treatment Drug Revenue by Application (2018-2029)
    6.3 US & Canada Alzheimer's Treatment Drug Market Size by Country
        6.3.1 US & Canada Alzheimer's Treatment Drug Revenue by Country: 2018 VS 2022 VS 2029
        6.3.2 US & Canada Alzheimer's Treatment Drug Sales by Country (2018-2029)
        6.3.3 US & Canada Alzheimer's Treatment Drug Revenue by Country (2018-2029)
        6.3.4 US
        6.3.5 Canada

 7 Europe
    7.1 Europe Alzheimer's Treatment Drug Market Size by Type
        7.1.1 Europe Alzheimer's Treatment Drug Sales by Type (2018-2029)
        7.1.2 Europe Alzheimer's Treatment Drug Revenue by Type (2018-2029)
    7.2 Europe Alzheimer's Treatment Drug Market Size by Application
        7.2.1 Europe Alzheimer's Treatment Drug Sales by Application (2018-2029)
        7.2.2 Europe Alzheimer's Treatment Drug Revenue by Application (2018-2029)
    7.3 Europe Alzheimer's Treatment Drug Market Size by Country
        7.3.1 Europe Alzheimer's Treatment Drug Revenue by Country: 2018 VS 2022 VS 2029
        7.3.2 Europe Alzheimer's Treatment Drug Sales by Country (2018-2029)
        7.3.3 Europe Alzheimer's Treatment Drug Revenue by Country (2018-2029)
        7.3.4 Germany
        7.3.5 France
        7.3.6 U.K.
        7.3.7 Italy
        7.3.8 Russia

 8 China
    8.1 China Alzheimer's Treatment Drug Market Size
        8.1.1 China Alzheimer's Treatment Drug Sales  (2018-2029)
        8.1.2 China Alzheimer's Treatment Drug Revenue  (2018-2029)
    8.2 China Alzheimer's Treatment Drug Market Size by Application
        8.2.1 China Alzheimer's Treatment Drug Sales by Application (2018-2029)
        8.2.2 China Alzheimer's Treatment Drug Revenue by Application (2018-2029)

 9 Asia (excluding China)
    9.1 Asia Alzheimer's Treatment Drug Market Size by Type
        9.1.1 Asia Alzheimer's Treatment Drug Sales by Type (2018-2029)
        9.1.2 Asia Alzheimer's Treatment Drug Revenue by Type (2018-2029)
    9.2 Asia Alzheimer's Treatment Drug Market Size by Application
        9.2.1 Asia Alzheimer's Treatment Drug Sales by Application (2018-2029)
        9.2.2 Asia Alzheimer's Treatment Drug Revenue by Application (2018-2029)
    9.3 Asia Alzheimer's Treatment Drug Sales by Region
        9.3.1 Asia Alzheimer's Treatment Drug Revenue by Region: 2018 VS 2022 VS 2029
        9.3.2 Asia Alzheimer's Treatment Drug Revenue by Region (2018-2029)
        9.3.3 Asia Alzheimer's Treatment Drug Sales by Region (2018-2029)
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 China Taiwan
        9.3.7 Southeast Asia
        9.3.8 India

 10 Middle East, Africa and Latin America
    10.1 Middle East, Africa and Latin America Alzheimer's Treatment Drug Market Size by Type
        10.1.1 Middle East, Africa and Latin America Alzheimer's Treatment Drug Sales by Type (2018-2029)
        10.1.2 Middle East, Africa and Latin America Alzheimer's Treatment Drug Revenue by Type (2018-2029)
    10.2 Middle East, Africa and Latin America Alzheimer's Treatment Drug Market Size by Application
        10.2.1 Middle East, Africa and Latin America Alzheimer's Treatment Drug Sales by Application (2018-2029)
        10.2.2 Middle East, Africa and Latin America Alzheimer's Treatment Drug Revenue by Application (2018-2029)
    10.3 Middle East, Africa and Latin America Alzheimer's Treatment Drug Sales by Country
        10.3.1 Middle East, Africa and Latin America Alzheimer's Treatment Drug Revenue by Country: 2018 VS 2022 VS 2029
        10.3.2 Middle East, Africa and Latin America Alzheimer's Treatment Drug Revenue by Country (2018-2029)
        10.3.3 Middle East, Africa and Latin America Alzheimer's Treatment Drug Sales by Country (2018-2029)
        10.3.4 Brazil
        10.3.5 Mexico
        10.3.6 Turkey
        10.3.7 Israel
        10.3.8 GCC Countries

 11 Company Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Information
        11.1.2 AbbVie Overview
        11.1.3 AbbVie Alzheimer's Treatment Drug Sales, Price, Revenue and Gross Margin (2018-2023)
        11.1.4 AbbVie Alzheimer's Treatment Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 AbbVie Recent Developments
    11.2 Eisai
        11.2.1 Eisai Company Information
        11.2.2 Eisai Overview
        11.2.3 Eisai Alzheimer's Treatment Drug Sales, Price, Revenue and Gross Margin (2018-2023)
        11.2.4 Eisai Alzheimer's Treatment Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Eisai Recent Developments
    11.3 Novartis
        11.3.1 Novartis Company Information
        11.3.2 Novartis Overview
        11.3.3 Novartis Alzheimer's Treatment Drug Sales, Price, Revenue and Gross Margin (2018-2023)
        11.3.4 Novartis Alzheimer's Treatment Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Novartis Recent Developments
    11.4 Daiichi Sankyo
        11.4.1 Daiichi Sankyo Company Information
        11.4.2 Daiichi Sankyo Overview
        11.4.3 Daiichi Sankyo Alzheimer's Treatment Drug Sales, Price, Revenue and Gross Margin (2018-2023)
        11.4.4 Daiichi Sankyo Alzheimer's Treatment Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Daiichi Sankyo Recent Developments
    11.5 Merz Pharma
        11.5.1 Merz Pharma Company Information
        11.5.2 Merz Pharma Overview
        11.5.3 Merz Pharma Alzheimer's Treatment Drug Sales, Price, Revenue and Gross Margin (2018-2023)
        11.5.4 Merz Pharma Alzheimer's Treatment Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Merz Pharma Recent Developments
    11.6 Pfizer
        11.6.1 Pfizer Company Information
        11.6.2 Pfizer Overview
        11.6.3 Pfizer Alzheimer's Treatment Drug Sales, Price, Revenue and Gross Margin (2018-2023)
        11.6.4 Pfizer Alzheimer's Treatment Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Pfizer Recent Developments
    11.7 Johnson and Johnson
        11.7.1 Johnson and Johnson Company Information
        11.7.2 Johnson and Johnson Overview
        11.7.3 Johnson and Johnson Alzheimer's Treatment Drug Sales, Price, Revenue and Gross Margin (2018-2023)
        11.7.4 Johnson and Johnson Alzheimer's Treatment Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Johnson and Johnson Recent Developments
    11.8 Lundbeck
        11.8.1 Lundbeck Company Information
        11.8.2 Lundbeck Overview
        11.8.3 Lundbeck Alzheimer's Treatment Drug Sales, Price, Revenue and Gross Margin (2018-2023)
        11.8.4 Lundbeck Alzheimer's Treatment Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Lundbeck Recent Developments

 12 Industry Chain and Sales Channels Analysis
    12.1 Alzheimer's Treatment Drug Industry Chain Analysis
    12.2 Alzheimer's Treatment Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Alzheimer's Treatment Drug Production Mode & Process
    12.4 Alzheimer's Treatment Drug Sales and Marketing
        12.4.1 Alzheimer's Treatment Drug Sales Channels
        12.4.2 Alzheimer's Treatment Drug Distributors
    12.5 Alzheimer's Treatment Drug Customers

 13 Market Dynamics
    13.1 Alzheimer's Treatment Drug Industry Trends
    13.2 Alzheimer's Treatment Drug Market Drivers
    13.3 Alzheimer's Treatment Drug Market Challenges
    13.4 Alzheimer's Treatment Drug Market Restraints

 14 Key Findings in The Global Alzheimer's Treatment Drug Study

 15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Alzheimer's Treatment Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Table 2. Major Manufacturers of Donepezil
    Table 3. Major Manufacturers of Memantine
    Table 4. Major Manufacturers of Rivastigmine
    Table 5. Global Alzheimer's Treatment Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Table 6. Global Alzheimer's Treatment Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. Global Alzheimer's Treatment Drug Revenue by Region (2018-2023) & (US$ Million)
    Table 8. Global Alzheimer's Treatment Drug Revenue by Region (2024-2029) & (US$ Million)
    Table 9. Global Alzheimer's Treatment Drug Revenue Market Share by Region (2018-2023)
    Table 10. Global Alzheimer's Treatment Drug Revenue Market Share by Region (2024-2029)
    Table 11. Global Alzheimer's Treatment Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 12. Global Alzheimer's Treatment Drug Sales by Region (2018-2023) & (K Pills)
    Table 13. Global Alzheimer's Treatment Drug Sales by Region (2024-2029) & (K Pills)
    Table 14. Global Alzheimer's Treatment Drug Sales Market Share by Region (2018-2023)
    Table 15. Global Alzheimer's Treatment Drug Sales Market Share by Region (2024-2029)
    Table 16. Global Alzheimer's Treatment Drug Sales by Manufacturers (2018-2023) & (K Pills)
    Table 17. Global Alzheimer's Treatment Drug Sales Share by Manufacturers (2018-2023)
    Table 18. Global Alzheimer's Treatment Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
    Table 19. Global Alzheimer's Treatment Drug Revenue Share by Manufacturers (2018-2023)
    Table 20. Global Key Players of Alzheimer's Treatment Drug, Industry Ranking, 2021 VS 2022 VS 2023
    Table 21. Alzheimer's Treatment Drug Price by Manufacturers 2018-2023 (US$/Pill)
    Table 22. Global Alzheimer's Treatment Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Alzheimer's Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Treatment Drug as of 2022)
    Table 24. Global Key Manufacturers of Alzheimer's Treatment Drug, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Alzheimer's Treatment Drug, Product Offered and Application
    Table 26. Global Key Manufacturers of Alzheimer's Treatment Drug, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Alzheimer's Treatment Drug Sales by Type (2018-2023) & (K Pills)
    Table 29. Global Alzheimer's Treatment Drug Sales by Type (2024-2029) & (K Pills)
    Table 30. Global Alzheimer's Treatment Drug Sales Share by Type (2018-2023)
    Table 31. Global Alzheimer's Treatment Drug Sales Share by Type (2024-2029)
    Table 32. Global Alzheimer's Treatment Drug Revenue by Type (2018-2023) & (US$ Million)
    Table 33. Global Alzheimer's Treatment Drug Revenue by Type (2024-2029) & (US$ Million)
    Table 34. Global Alzheimer's Treatment Drug Revenue Share by Type (2018-2023)
    Table 35. Global Alzheimer's Treatment Drug Revenue Share by Type (2024-2029)
    Table 36. Alzheimer's Treatment Drug Price by Type (2018-2023) & (US$/Pill)
    Table 37. Global Alzheimer's Treatment Drug Price Forecast by Type (2024-2029) & (US$/Pill)
    Table 38. Global Alzheimer's Treatment Drug Sales by Application (2018-2023) & (K Pills)
    Table 39. Global Alzheimer's Treatment Drug Sales by Application (2024-2029) & (K Pills)
    Table 40. Global Alzheimer's Treatment Drug Sales Share by Application (2018-2023)
    Table 41. Global Alzheimer's Treatment Drug Sales Share by Application (2024-2029)
    Table 42. Global Alzheimer's Treatment Drug Revenue by Application (2018-2023) & (US$ Million)
    Table 43. Global Alzheimer's Treatment Drug Revenue by Application (2024-2029) & (US$ Million)
    Table 44. Global Alzheimer's Treatment Drug Revenue Share by Application (2018-2023)
    Table 45. Global Alzheimer's Treatment Drug Revenue Share by Application (2024-2029)
    Table 46. Alzheimer's Treatment Drug Price by Application (2018-2023) & (US$/Pill)
    Table 47. Global Alzheimer's Treatment Drug Price Forecast by Application (2024-2029) & (US$/Pill)
    Table 48. US & Canada Alzheimer's Treatment Drug Sales by Type (2018-2023) & (K Pills)
    Table 49. US & Canada Alzheimer's Treatment Drug Sales by Type (2024-2029) & (K Pills)
    Table 50. US & Canada Alzheimer's Treatment Drug Revenue by Type (2018-2023) & (US$ Million)
    Table 51. US & Canada Alzheimer's Treatment Drug Revenue by Type (2024-2029) & (US$ Million)
    Table 52. US & Canada Alzheimer's Treatment Drug Sales by Application (2018-2023) & (K Pills)
    Table 53. US & Canada Alzheimer's Treatment Drug Sales by Application (2024-2029) & (K Pills)
    Table 54. US & Canada Alzheimer's Treatment Drug Revenue by Application (2018-2023) & (US$ Million)
    Table 55. US & Canada Alzheimer's Treatment Drug Revenue by Application (2024-2029) & (US$ Million)
    Table 56. US & Canada Alzheimer's Treatment Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 57. US & Canada Alzheimer's Treatment Drug Revenue by Country (2018-2023) & (US$ Million)
    Table 58. US & Canada Alzheimer's Treatment Drug Revenue by Country (2024-2029) & (US$ Million)
    Table 59. US & Canada Alzheimer's Treatment Drug Sales by Country (2018-2023) & (K Pills)
    Table 60. US & Canada Alzheimer's Treatment Drug Sales by Country (2024-2029) & (K Pills)
    Table 61. Europe Alzheimer's Treatment Drug Sales by Type (2018-2023) & (K Pills)
    Table 62. Europe Alzheimer's Treatment Drug Sales by Type (2024-2029) & (K Pills)
    Table 63. Europe Alzheimer's Treatment Drug Revenue by Type (2018-2023) & (US$ Million)
    Table 64. Europe Alzheimer's Treatment Drug Revenue by Type (2024-2029) & (US$ Million)
    Table 65. Europe Alzheimer's Treatment Drug Sales by Application (2018-2023) & (K Pills)
    Table 66. Europe Alzheimer's Treatment Drug Sales by Application (2024-2029) & (K Pills)
    Table 67. Europe Alzheimer's Treatment Drug Revenue by Application (2018-2023) & (US$ Million)
    Table 68. Europe Alzheimer's Treatment Drug Revenue by Application (2024-2029) & (US$ Million)
    Table 69. Europe Alzheimer's Treatment Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 70. Europe Alzheimer's Treatment Drug Revenue by Country (2018-2023) & (US$ Million)
    Table 71. Europe Alzheimer's Treatment Drug Revenue by Country (2024-2029) & (US$ Million)
    Table 72. Europe Alzheimer's Treatment Drug Sales by Country (2018-2023) & (K Pills)
    Table 73. Europe Alzheimer's Treatment Drug Sales by Country (2024-2029) & (K Pills)
    Table 74. China Alzheimer's Treatment Drug Sales by Type (2018-2023) & (K Pills)
    Table 75. China Alzheimer's Treatment Drug Sales by Type (2024-2029) & (K Pills)
    Table 76. China Alzheimer's Treatment Drug Revenue by Type (2018-2023) & (US$ Million)
    Table 77. China Alzheimer's Treatment Drug Revenue by Type (2024-2029) & (US$ Million)
    Table 78. China Alzheimer's Treatment Drug Sales by Application (2018-2023) & (K Pills)
    Table 79. China Alzheimer's Treatment Drug Sales by Application (2024-2029) & (K Pills)
    Table 80. China Alzheimer's Treatment Drug Revenue by Application (2018-2023) & (US$ Million)
    Table 81. China Alzheimer's Treatment Drug Revenue by Application (2024-2029) & (US$ Million)
    Table 82. Asia Alzheimer's Treatment Drug Sales by Type (2018-2023) & (K Pills)
    Table 83. Asia Alzheimer's Treatment Drug Sales by Type (2024-2029) & (K Pills)
    Table 84. Asia Alzheimer's Treatment Drug Revenue by Type (2018-2023) & (US$ Million)
    Table 85. Asia Alzheimer's Treatment Drug Revenue by Type (2024-2029) & (US$ Million)
    Table 86. Asia Alzheimer's Treatment Drug Sales by Application (2018-2023) & (K Pills)
    Table 87. Asia Alzheimer's Treatment Drug Sales by Application (2024-2029) & (K Pills)
    Table 88. Asia Alzheimer's Treatment Drug Revenue by Application (2018-2023) & (US$ Million)
    Table 89. Asia Alzheimer's Treatment Drug Revenue by Application (2024-2029) & (US$ Million)
    Table 90. Asia Alzheimer's Treatment Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 91. Asia Alzheimer's Treatment Drug Revenue by Region (2018-2023) & (US$ Million)
    Table 92. Asia Alzheimer's Treatment Drug Revenue by Region (2024-2029) & (US$ Million)
    Table 93. Asia Alzheimer's Treatment Drug Sales by Region (2018-2023) & (K Pills)
    Table 94. Asia Alzheimer's Treatment Drug Sales by Region (2024-2029) & (K Pills)
    Table 95. Middle East, Africa and Latin America Alzheimer's Treatment Drug Sales by Type (2018-2023) & (K Pills)
    Table 96. Middle East, Africa and Latin America Alzheimer's Treatment Drug Sales by Type (2024-2029) & (K Pills)
    Table 97. Middle East, Africa and Latin America Alzheimer's Treatment Drug Revenue by Type (2018-2023) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Alzheimer's Treatment Drug Revenue by Type (2024-2029) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Alzheimer's Treatment Drug Sales by Application (2018-2023) & (K Pills)
    Table 100. Middle East, Africa and Latin America Alzheimer's Treatment Drug Sales by Application (2024-2029) & (K Pills)
    Table 101. Middle East, Africa and Latin America Alzheimer's Treatment Drug Revenue by Application (2018-2023) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Alzheimer's Treatment Drug Revenue by Application (2024-2029) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Alzheimer's Treatment Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 104. Middle East, Africa and Latin America Alzheimer's Treatment Drug Revenue by Country (2018-2023) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Alzheimer's Treatment Drug Revenue by Country (2024-2029) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Alzheimer's Treatment Drug Sales by Country (2018-2023) & (K Pills)
    Table 107. Middle East, Africa and Latin America Alzheimer's Treatment Drug Sales by Country (2024-2029) & (K Pills)
    Table 108. AbbVie Company Information
    Table 109. AbbVie Description and Major Businesses
    Table 110. AbbVie Alzheimer's Treatment Drug Sales (K Pills), Revenue (US$ Million), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 111. AbbVie Alzheimer's Treatment Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. AbbVie Recent Developments
    Table 113. Eisai Company Information
    Table 114. Eisai Description and Major Businesses
    Table 115. Eisai Alzheimer's Treatment Drug Sales (K Pills), Revenue (US$ Million), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 116. Eisai Alzheimer's Treatment Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Eisai Recent Developments
    Table 118. Novartis Company Information
    Table 119. Novartis Description and Major Businesses
    Table 120. Novartis Alzheimer's Treatment Drug Sales (K Pills), Revenue (US$ Million), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 121. Novartis Alzheimer's Treatment Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Novartis Recent Developments
    Table 123. Daiichi Sankyo Company Information
    Table 124. Daiichi Sankyo Description and Major Businesses
    Table 125. Daiichi Sankyo Alzheimer's Treatment Drug Sales (K Pills), Revenue (US$ Million), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 126. Daiichi Sankyo Alzheimer's Treatment Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Daiichi Sankyo Recent Developments
    Table 128. Merz Pharma Company Information
    Table 129. Merz Pharma Description and Major Businesses
    Table 130. Merz Pharma Alzheimer's Treatment Drug Sales (K Pills), Revenue (US$ Million), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 131. Merz Pharma Alzheimer's Treatment Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Merz Pharma Recent Developments
    Table 133. Pfizer Company Information
    Table 134. Pfizer Description and Major Businesses
    Table 135. Pfizer Alzheimer's Treatment Drug Sales (K Pills), Revenue (US$ Million), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 136. Pfizer Alzheimer's Treatment Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Pfizer Recent Developments
    Table 138. Johnson and Johnson Company Information
    Table 139. Johnson and Johnson Description and Major Businesses
    Table 140. Johnson and Johnson Alzheimer's Treatment Drug Sales (K Pills), Revenue (US$ Million), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 141. Johnson and Johnson Alzheimer's Treatment Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Johnson and Johnson Recent Developments
    Table 143. Lundbeck Company Information
    Table 144. Lundbeck Description and Major Businesses
    Table 145. Lundbeck Alzheimer's Treatment Drug Sales (K Pills), Revenue (US$ Million), Price (US$/Pill) and Gross Margin (2018-2023)
    Table 146. Lundbeck Alzheimer's Treatment Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Lundbeck Recent Developments
    Table 148. Key Raw Materials Lists
    Table 149. Raw Materials Key Suppliers Lists
    Table 150. Alzheimer's Treatment Drug Distributors List
    Table 151. Alzheimer's Treatment Drug Customers List
    Table 152. Alzheimer's Treatment Drug Market Trends
    Table 153. Alzheimer's Treatment Drug Market Drivers
    Table 154. Alzheimer's Treatment Drug Market Challenges
    Table 155. Alzheimer's Treatment Drug Market Restraints
    Table 156. Research Programs/Design for This Report
    Table 157. Key Data Information from Secondary Sources
    Table 158. Key Data Information from Primary Sources
List of Figures
    Figure 1. Alzheimer's Treatment Drug Product Picture
    Figure 2. Global Alzheimer's Treatment Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Alzheimer's Treatment Drug Market Share by Type in 2022 & 2029
    Figure 4. Donepezil Product Picture
    Figure 5. Memantine Product Picture
    Figure 6. Rivastigmine Product Picture
    Figure 7. Global Alzheimer's Treatment Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 8. Global Alzheimer's Treatment Drug Market Share by Application in 2022 & 2029
    Figure 9. Early to Moderate Stages
    Figure 10. Moderate to Severe Stages
    Figure 11. Alzheimer's Treatment Drug Report Years Considered
    Figure 12. Global Alzheimer's Treatment Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Alzheimer's Treatment Drug Revenue 2018-2029 (US$ Million)
    Figure 14. Global Alzheimer's Treatment Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
    Figure 15. Global Alzheimer's Treatment Drug Revenue Market Share by Region (2018-2029)
    Figure 16. Global Alzheimer's Treatment Drug Sales 2018-2029 ((K Pills)
    Figure 17. Global Alzheimer's Treatment Drug Sales Market Share by Region (2018-2029)
    Figure 18. US & Canada Alzheimer's Treatment Drug Sales YoY (2018-2029) & (K Pills)
    Figure 19. US & Canada Alzheimer's Treatment Drug Revenue YoY (2018-2029) & (US$ Million)
    Figure 20. Europe Alzheimer's Treatment Drug Sales YoY (2018-2029) & (K Pills)
    Figure 21. Europe Alzheimer's Treatment Drug Revenue YoY (2018-2029) & (US$ Million)
    Figure 22. China Alzheimer's Treatment Drug Sales YoY (2018-2029) & (K Pills)
    Figure 23. China Alzheimer's Treatment Drug Revenue YoY (2018-2029) & (US$ Million)
    Figure 24. Asia (excluding China) Alzheimer's Treatment Drug Sales YoY (2018-2029) & (K Pills)
    Figure 25. Asia (excluding China) Alzheimer's Treatment Drug Revenue YoY (2018-2029) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Alzheimer's Treatment Drug Sales YoY (2018-2029) & (K Pills)
    Figure 27. Middle East, Africa and Latin America Alzheimer's Treatment Drug Revenue YoY (2018-2029) & (US$ Million)
    Figure 28. The Alzheimer's Treatment Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
    Figure 29. The Top 5 and 10 Largest Manufacturers of Alzheimer's Treatment Drug in the World: Market Share by Alzheimer's Treatment Drug Revenue in 2022
    Figure 30. Global Alzheimer's Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 31. Global Alzheimer's Treatment Drug Sales Market Share by Type (2018-2029)
    Figure 32. Global Alzheimer's Treatment Drug Revenue Market Share by Type (2018-2029)
    Figure 33. Global Alzheimer's Treatment Drug Sales Market Share by Application (2018-2029)
    Figure 34. Global Alzheimer's Treatment Drug Revenue Market Share by Application (2018-2029)
    Figure 35. US & Canada Alzheimer's Treatment Drug Sales Market Share by Type (2018-2029)
    Figure 36. US & Canada Alzheimer's Treatment Drug Revenue Market Share by Type (2018-2029)
    Figure 37. US & Canada Alzheimer's Treatment Drug Sales Market Share by Application (2018-2029)
    Figure 38. US & Canada Alzheimer's Treatment Drug Revenue Market Share by Application (2018-2029)
    Figure 39. US & Canada Alzheimer's Treatment Drug Revenue Share by Country (2018-2029)
    Figure 40. US & Canada Alzheimer's Treatment Drug Sales Share by Country (2018-2029)
    Figure 41. U.S. Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 42. Canada Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 43. Europe Alzheimer's Treatment Drug Sales Market Share by Type (2018-2029)
    Figure 44. Europe Alzheimer's Treatment Drug Revenue Market Share by Type (2018-2029)
    Figure 45. Europe Alzheimer's Treatment Drug Sales Market Share by Application (2018-2029)
    Figure 46. Europe Alzheimer's Treatment Drug Revenue Market Share by Application (2018-2029)
    Figure 47. Europe Alzheimer's Treatment Drug Revenue Share by Country (2018-2029)
    Figure 48. Europe Alzheimer's Treatment Drug Sales Share by Country (2018-2029)
    Figure 49. Germany Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 50. France Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 51. U.K. Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 52. Italy Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 53. Russia Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 54. China Alzheimer's Treatment Drug Sales Market Share by Type (2018-2029)
    Figure 55. China Alzheimer's Treatment Drug Revenue Market Share by Type (2018-2029)
    Figure 56. China Alzheimer's Treatment Drug Sales Market Share by Application (2018-2029)
    Figure 57. China Alzheimer's Treatment Drug Revenue Market Share by Application (2018-2029)
    Figure 58. Asia Alzheimer's Treatment Drug Sales Market Share by Type (2018-2029)
    Figure 59. Asia Alzheimer's Treatment Drug Revenue Market Share by Type (2018-2029)
    Figure 60. Asia Alzheimer's Treatment Drug Sales Market Share by Application (2018-2029)
    Figure 61. Asia Alzheimer's Treatment Drug Revenue Market Share by Application (2018-2029)
    Figure 62. Asia Alzheimer's Treatment Drug Revenue Share by Region (2018-2029)
    Figure 63. Asia Alzheimer's Treatment Drug Sales Share by Region (2018-2029)
    Figure 64. Japan Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 65. South Korea Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 66. China Taiwan Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 67. Southeast Asia Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 68. India Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Alzheimer's Treatment Drug Sales Market Share by Type (2018-2029)
    Figure 70. Middle East, Africa and Latin America Alzheimer's Treatment Drug Revenue Market Share by Type (2018-2029)
    Figure 71. Middle East, Africa and Latin America Alzheimer's Treatment Drug Sales Market Share by Application (2018-2029)
    Figure 72. Middle East, Africa and Latin America Alzheimer's Treatment Drug Revenue Market Share by Application (2018-2029)
    Figure 73. Middle East, Africa and Latin America Alzheimer's Treatment Drug Revenue Share by Country (2018-2029)
    Figure 74. Middle East, Africa and Latin America Alzheimer's Treatment Drug Sales Share by Country (2018-2029)
    Figure 75. Brazil Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 76. Mexico Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 77. Turkey Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 78. Israel Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 79. GCC Countries Alzheimer's Treatment Drug Revenue (2018-2029) & (US$ Million)
    Figure 80. Alzheimer's Treatment Drug Value Chain
    Figure 81. Alzheimer's Treatment Drug Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed

Description

The global Alzheimer's Treatment Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Alzheimer's Treatment Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Alzheimer's Treatment Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Alzheimer's Treatment Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Descriptive company profiles of the major global players, including AbbVie, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson and Johnson and Lundbeck, etc.

Industry: Pharma & Healthcare

Published: 2023-05-31

Pages: 94 Pages

Report ld: 1154805

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 4900.00

Multi Users License

USD 7350.00

Corporate Users License